Anti-CD40-induced inflammatory E-cadherin+ dendritic cells enhance T cell responses and antitumour immunity in murine Lewis lung carcinoma

BACKGROUND: Agonistic CD40 antibodies have been demonstrated to activate antigen-presenting cells (APCs) and enhance antitumour T cell responses, thereby providing a new therapeutic option in cancer immunotherapy. In agonistic CD40 antibody-mediated inflammatory responses, a novel subset of E-cadher...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yong, Hu, Xiaoyan, Hu, Yue, Teng, Kai, Zhang, Kai, Zheng, Yamei, Hong, Xiaohua, Yu, Kunwu, Wang, Yan, Liu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323023/
https://www.ncbi.nlm.nih.gov/pubmed/25651850
http://dx.doi.org/10.1186/s13046-015-0126-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323023/
https://www.ncbi.nlm.nih.gov/pubmed/25651850
http://dx.doi.org/10.1186/s13046-015-0126-9

Ejemplares similares